Profile for Russian Federation Patent: 2727509
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Russian Federation Patent: 2727509
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Aug 12, 2031 | Abbvie | AVYCAZ | avibactam sodium; ceftazidime |
| ⤷ Start Trial | Aug 12, 2031 | Abbvie | EMBLAVEO | avibactam sodium; aztreonam |
| ⤷ Start Trial | Oct 8, 2030 | Abbvie | AVYCAZ | avibactam sodium; ceftazidime |
| ⤷ Start Trial | Oct 8, 2030 | Abbvie | EMBLAVEO | avibactam sodium; aztreonam |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
